Permira Beteiligungsberatung has acquired Neuraxpharm from Apax Partners.
We acted as advisor to the buyer.
EOS AG and the founding shareholders have sold 100% of the shares in Microbeads A/S to Lamberti group.
We initiated the transaction and acted as advisor to EOS AG and the founding shareholders.
Bader Holding GmbH, Senden has sold selective manufacturing subsidiaries and operating assets of the Bader Group, a leading supplier of machine covers and housings to the European machinery industry, to a group of investors led by GFEP GmbH.
We initiated the transaction and acted as advisor to the shareholders of Bader Holding GmbH.
The Apotal group has sold its mail-order pharmaceuticals and diabetes activities to Zur Rose group.
We initiated the transaction and acted as advisor to Heinz-Peter Fichter and Apotal group.
Dermapharm has acquired Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA.
We acted as advisor to the buyer.
Capiton has assumed a minority ownership stake in Alphapet Ventures, a leader in the premium pet food market, acquiring Healthfood24 (Wolfsblut).
We initiated the transaction and advised Capiton and Alphapet Ventures on the realignment of the shareholder base.
Dermapharm AG has acquired 70% of the shares in Fitvia GmbH.
We acted as advisor to the buyer.
Advent International has acquried Lavorel Medicare and Bonitas.
We acted as advisor to the buyer.
Katjes International has sold its minority ownership stake in Halloren Schokoladenfabrik AG to Charlie Investors S.à.r.l.
We acted as advisor to the seller.
Point Rouge has acquired ascopharm from Pagoda and Adiuva Capital.
We acted as advisor to the buyer.